Mesenchymal stem cell transplantation in T1DM patients: Experience of the endocrinology and diabetology department of Marrakech University Hospital | ||
Egyptian Society of Diabetes and Lipidology Journal | ||
Volume 3, Issue 2, October 2023 PDF (818.02 K) | ||
Document Type: Abstracts | ||
DOI: 10.21608/esdlj.2023.456202 | ||
Abstract | ||
According to many studies, mesenchymal stem cell (MSC) therapy derived from adipose tissue is one of the best therapeutic approaches for the treatment of type 1 diabetes. Indeed, MSCs have several characteristics: ease of harvesting and isolation, abundance, their potential to differentiate into multiple lineages, secretion of various cytokines and growth factors, as well as their immunomodulatory effects. | ||
Statistics Article View: 1 |